ArticleNature cancer2025

Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes.

Bing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.